Pages that link to "Q33375739"
Jump to navigation
Jump to search
The following pages link to Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? (Q33375739):
Displaying 50 items.
- A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury (Q26992169) (← links)
- Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment (Q28069228) (← links)
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue (Q30276550) (← links)
- Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment (Q33383355) (← links)
- Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteria (Q33384578) (← links)
- Thrombocytopenia and hemostatic disorders in chronic graft versus host disease (Q33385836) (← links)
- Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning (Q33386036) (← links)
- Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange (Q33386308) (← links)
- Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT. (Q33391308) (← links)
- Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation (Q33392710) (← links)
- Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease (Q33393068) (← links)
- Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation (Q33393944) (← links)
- Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center (Q33394558) (← links)
- Do NK cells contribute to the pathophysiology of transplant-associated thrombotic microangiopathy? (Q33395998) (← links)
- Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. (Q33396969) (← links)
- Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation. (Q33398627) (← links)
- Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy? (Q33402385) (← links)
- Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis (Q33403897) (← links)
- Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy (Q33407913) (← links)
- Using rheopheresis for stem cell transplantation-associated thrombotic microangiopathy (TA-TMA). (Q33408395) (← links)
- Idiopathic pneumonia syndrome with thrombotic microangiopathy-related changes after allogeneic hematopoietic stem cell transplantation (Q33409874) (← links)
- Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy. (Q33412325) (← links)
- Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus (Q33413498) (← links)
- Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults (Q33415603) (← links)
- Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant (Q33417690) (← links)
- Fragmented Red Cell as a Possible Favorable Prognostic Marker of Hematopoietic Stem Cell Transplantation Associated Thrombotic Microangiopathy. (Q33418635) (← links)
- Pretransplant-corrected QT dispersion as a predictor of pericardial effusion after pediatric hematopoietic stem cell transplantation (Q33420131) (← links)
- Hematopoietic stem cell transplantation-associated thrombotic microangiopathy accompanied by renal arteriolar C4d deposition (Q33420858) (← links)
- Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant. (Q33421514) (← links)
- The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy (Q33424153) (← links)
- Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (Q33424902) (← links)
- Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin (Q33428744) (← links)
- Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis (Q34122035) (← links)
- Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States (Q34448474) (← links)
- Emergent Complications in the Pediatric Hematopoietic Stem Cell Transplant Patient (Q34522746) (← links)
- Alterations of hemostatic parameters in the early development of allogeneic hematopoietic stem cell transplantation-related complications (Q35200663) (← links)
- Cyclosporin A impairs the secretion and activity of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat). (Q36492812) (← links)
- The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate (Q36862464) (← links)
- Neurological complications of transplantation: part I: hematopoietic cell transplantation (Q38132157) (← links)
- Therapeutic apheresis for patients with cancer (Q38287610) (← links)
- Onco-nephrology: current concepts and future perspectives (Q38382457) (← links)
- Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD. (Q38709053) (← links)
- Acute kidney injury in HCT: an update (Q38726036) (← links)
- Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy? (Q38806679) (← links)
- Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation. (Q38902112) (← links)
- Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation (Q40096407) (← links)
- Severe transplant-associated thrombotic microangiopathy in patients with hemoglobinopathies (Q40281926) (← links)
- Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation (Q41685216) (← links)
- Central nervous system complications after allogeneic hematopoietic stem cell transplantation (Q41923053) (← links)
- Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies. (Q41992358) (← links)